- Home
- PERI vs AMRN Comparison
PERI vs AMRN Comparison
Compare PERI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PERI | AMRN |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | Israel | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.5M | 287.9M |
| IPO Year | 2005 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PERI | AMRN |
|---|---|---|
| Price | $11.39 | $11.35 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $12.90 | $12.50 |
| AVG Volume (30 Days) | ★ 755.0K | 73.0K |
| Earning Date | 11-16-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $10.33 | $3.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $7.63 | $11.25 |
| 52 Week High | $11.46 | $17.31 |
Technical Indicators
Market Signals| Indicator | PERI | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 78.63 | 36.60 |
| Support Level | $8.36 | N/A |
| Resistance Level | $11.46 | $15.34 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 97.30 | 1.63 |
Price Performance
Historical ComparisonAbout PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.